Numaferm have developed a disruptive bioprocess that dramatically lowers the cost of peptide production. Their peptides then go on to be used pharmaceutical purposes, as well as cosmeceuticals, adhesives, and many more applications.
WHO: Hilke Wobst, Senior Scientist
WHEN: Founded in 2017
RING EXPERIENCE: Winner Get in the Ring Madrid 2019